Trial intelligence / Profile preview

Effect of Polyethylene Glycol on Intestinal Inflammation in Children With Cystic Fibrosis

NCT04458129Phase 2Terminated

Sponsor
Centre Hospitalier Universitaire de Bordeaux
Start
Sep 2020
Primary completion
Apr 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of polyethylene glycol 3350 + bisacodyl in cystic fibrosis (CF), sponsored by Centre Hospitalier Universitaire de Bordeaux. Started Sep 2020; status: terminated.

02

Drugs

polyethylene glycol 3350 + bisacodyl
03

Conditions

cystic fibrosis (CF)

Beyond the preview

Go deeper on NCT04458129.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04458129.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call